About this trial
Early feasibility study to establish quantitative physiological markers correlated with noninvasive stimulation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Able to provide written informed consent in English.
Willing and able to complete study procedures (e.g., ~1-hour sessions with non-invasive recordings, ~3-hour visit).
Disqualifiers
History of neurological disorders (e.g., epilepsy, migraines) or psychiatric conditions requiring medication.
Active implanted medical devices (e.g., pacemakers, cochlear implants) or metal in the neck/forearm that could interfere with stimulation or recordings.
Skin conditions or open wounds at stimulation sites (cervical neck, forearm).
Women who are pregnant or breastfeeding.
Trial design
Crossover
Treatments tested in this trial
External electrical stimulation
DeviceElectrical stimulation
Ultrasound stimulation
DeviceUSS
Treatment groups
Trial outcomes
Primary outcomes
Change From Baseline in HD-EEG Power Spectrum Magnitude After Active Versus Sham Stimulation
Change from baseline in power spectrum magnitude will be calculated from high-density electroencephalography recordings in standard EEG frequency bands. The primary comparison will be the within-participant difference in change from baseline between active stimulation and sham stimulation conditions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.